FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322760769> ?p ?o ?g. }

• W4322760769 endingPage "572" @default.
• W4322760769 startingPage "572" @default.
• W4322760769 abstract "Immunogenicity after SARS-CoV-2 vaccination is known to be impaired in liver transplant (LT) recipients, but the results after the application of a third dose show significant improvement in seroconversion rates. In the general population, the antibody response wanes over the course of time after two doses of the vaccination, but seems to be more robust after the application of three doses. Still, the durability of the antibody response in LT recipients who receive a third dose of SARS-CoV-2 vaccination has not been analyzed yet. We therefore assessed antibody responses in a total of 300 LT recipients and observed antibody titers for six months each after patients had received the second and the third doses of the vaccination, explicitly excluding all patients who had suffered from SARS-CoV-2 infection. The initial antibody response was compared to a control group of 122 healthcare workers. After the application of two doses of the vaccination, 74% of LT recipients (158 out of 213) developed antibodies against SARS-CoV-2; this result depended significantly on whether the patients were taking the medication mycophenolate mofetil, and on the age of the patients. Antibody titers declined significantly within six months from 407 BAU/mL (IQR: 0-1865) to 105 BAU/mL (IQR: 0-145) (p ≤ 0.001), but increased after the application of the third vaccine dose in 92% of patients (105 out of 114), showing an antibody response (p ≤ 0.001). After a further six-month period, despite showing a decline from 2055 BAU/mL (IQR: 500 to >2080) to 1805 BAU/mL (IQR: 517 to >2080), the waning of antibody titers was not significant (p = 0.706), and antibody durability appeared to be more robust than that after the second dose. In conclusion, our study confirms the high efficacy of the application of a third dose of SARS-CoV-2 vaccination in LT recipients, and a reasonably sustained humoral response with superior durability in comparison to antibody kinetics after the application of the second dose of the vaccination." @default.
• W4322760769 created "2023-03-03" @default.
• W4322760769 creator A5014342463 @default.
• W4322760769 creator A5016126468 @default.
• W4322760769 creator A5030635588 @default.
• W4322760769 creator A5036432950 @default.
• W4322760769 creator A5042025828 @default.
• W4322760769 creator A5048956470 @default.
• W4322760769 creator A5054727724 @default.
• W4322760769 creator A5061317304 @default.
• W4322760769 creator A5068588579 @default.
• W4322760769 creator A5089060660 @default.
• W4322760769 date "2023-03-02" @default.
• W4322760769 modified "2023-10-14" @default.
• W4322760769 title "Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients" @default.
• W4322760769 cites W3154381950 @default.
• W4322760769 cites W3163785571 @default.
• W4322760769 cites W3174017401 @default.
• W4322760769 cites W3175067373 @default.
• W4322760769 cites W3176897911 @default.
• W4322760769 cites W3180841149 @default.
• W4322760769 cites W3184172540 @default.
• W4322760769 cites W3190427561 @default.
• W4322760769 cites W3193259004 @default.
• W4322760769 cites W3195684832 @default.
• W4322760769 cites W3196469881 @default.
• W4322760769 cites W3201358586 @default.
• W4322760769 cites W3210910530 @default.
• W4322760769 cites W3213337029 @default.
• W4322760769 cites W3217661335 @default.
• W4322760769 cites W4205450560 @default.
• W4322760769 cites W4207016828 @default.
• W4322760769 cites W4210791344 @default.
• W4322760769 cites W4214501050 @default.
• W4322760769 cites W4224269776 @default.
• W4322760769 cites W4225505755 @default.
• W4322760769 cites W4225854071 @default.
• W4322760769 cites W4226376477 @default.
• W4322760769 cites W4282021039 @default.
• W4322760769 cites W4283824092 @default.
• W4322760769 cites W4285602968 @default.
• W4322760769 cites W4294018714 @default.
• W4322760769 cites W4295898295 @default.
• W4322760769 cites W4296757094 @default.
• W4322760769 cites W4304757220 @default.
• W4322760769 cites W4319656479 @default.
• W4322760769 doi "https://doi.org/10.3390/vaccines11030572" @default.
• W4322760769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36992156" @default.
• W4322760769 hasPublicationYear "2023" @default.
• W4322760769 type Work @default.
• W4322760769 citedByCount "1" @default.
• W4322760769 countsByYear W43227607692023 @default.
• W4322760769 crossrefType "journal-article" @default.
• W4322760769 hasAuthorship W4322760769A5014342463 @default.
• W4322760769 hasAuthorship W4322760769A5016126468 @default.
• W4322760769 hasAuthorship W4322760769A5030635588 @default.
• W4322760769 hasAuthorship W4322760769A5036432950 @default.
• W4322760769 hasAuthorship W4322760769A5042025828 @default.
• W4322760769 hasAuthorship W4322760769A5048956470 @default.
• W4322760769 hasAuthorship W4322760769A5054727724 @default.
• W4322760769 hasAuthorship W4322760769A5061317304 @default.
• W4322760769 hasAuthorship W4322760769A5068588579 @default.
• W4322760769 hasAuthorship W4322760769A5089060660 @default.
• W4322760769 hasBestOaLocation W43227607691 @default.
• W4322760769 hasConcept C126322002 @default.
• W4322760769 hasConcept C159654299 @default.
• W4322760769 hasConcept C203014093 @default.
• W4322760769 hasConcept C22070199 @default.
• W4322760769 hasConcept C22889606 @default.
• W4322760769 hasConcept C2777451964 @default.
• W4322760769 hasConcept C2780868878 @default.
• W4322760769 hasConcept C2908647359 @default.
• W4322760769 hasConcept C3018913218 @default.
• W4322760769 hasConcept C32611913 @default.
• W4322760769 hasConcept C71924100 @default.
• W4322760769 hasConcept C99454951 @default.
• W4322760769 hasConceptScore W4322760769C126322002 @default.
• W4322760769 hasConceptScore W4322760769C159654299 @default.
• W4322760769 hasConceptScore W4322760769C203014093 @default.
• W4322760769 hasConceptScore W4322760769C22070199 @default.
• W4322760769 hasConceptScore W4322760769C22889606 @default.
• W4322760769 hasConceptScore W4322760769C2777451964 @default.
• W4322760769 hasConceptScore W4322760769C2780868878 @default.
• W4322760769 hasConceptScore W4322760769C2908647359 @default.
• W4322760769 hasConceptScore W4322760769C3018913218 @default.
• W4322760769 hasConceptScore W4322760769C32611913 @default.
• W4322760769 hasConceptScore W4322760769C71924100 @default.
• W4322760769 hasConceptScore W4322760769C99454951 @default.
• W4322760769 hasIssue "3" @default.
• W4322760769 hasLocation W43227607691 @default.
• W4322760769 hasLocation W43227607692 @default.
• W4322760769 hasLocation W43227607693 @default.
• W4322760769 hasOpenAccess W4322760769 @default.
• W4322760769 hasPrimaryLocation W43227607691 @default.
• W4322760769 hasRelatedWork W1934038313 @default.
• W4322760769 hasRelatedWork W2038899530 @default.
• W4322760769 hasRelatedWork W2039991482 @default.
• W4322760769 hasRelatedWork W2152467147 @default.

• next